Product Information
LACOSAMIDE 50 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.1186 per EA under NDC 33342030209. Its NADAC has been published 83 times since Mar 5, 2025.
FDA first approved this application on May 24, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342030209
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LACOSAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208466FDA Approved
5/24/2024
TE Code
AB
On Market Since
5/24/2024
Pharmacological Classes
Price Statistics
The NADAC for LACOSAMIDE 50 MG TABLET has been published 83 times since Mar 5, 2025, and over the history we have for it it has declined 20.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1186 per EA |
|---|---|
| All-time high | $0.1512 (Apr 16, 2025) |
| All-time low | $0.1046 (Apr 22, 2026) |
| 52-week high | $0.1336 |
| 52-week low | $0.1046 |
| Median price | $0.1293 |
| Average price | $0.1265 |
| Largest weekly change | -10.6% (Feb 18, 2026) |
| Weeks tracked | 83 |
| Tracking since | Mar 5, 2025 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lacosamide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LACOSAMIDE 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LACOSAMIDE 50 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.1186 per EA (NDC 33342030209), effective Sep 30, 2026.
How has the price of LACOSAMIDE 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for LACOSAMIDE 50 MG TABLET has declined 20.2%. It has been tracked across 83 weekly CMS publications since Mar 5, 2025.
What are the highest and lowest recorded NADAC prices for LACOSAMIDE 50 MG TABLET?
Since Mar 5, 2025, the NADAC for LACOSAMIDE 50 MG TABLET has ranged from a low of $0.1046 (Apr 22, 2026) to a high of $0.1512 (Apr 16, 2025), with a median of $0.1293 per EA.
Are there cheaper alternatives to LACOSAMIDE 50 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LACOSAMIDE 50 MG TABLET, is $0.1061 per EA — about 11% below LACOSAMIDE 50 MG TABLET.
Who manufactures LACOSAMIDE 50 MG TABLET?
LACOSAMIDE 50 MG TABLET (NDC 33342030209) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.